Stay updated on Magrolimab Combo in New AML/HR-MDS Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in New AML/HR-MDS Clinical Trial page.

Latest updates to the Magrolimab Combo in New AML/HR-MDS Clinical Trial page
- Check3 days agoChange DetectedThe funding-related notice about information potentially not being up to date was removed from the page. This change eliminates a transparency warning regarding data currency on the trial record.SummaryDifference0.8%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRecord History now shows updates to Study Status on 2023-08-17 and 2023-11-28, and a Recruitment Status update on 2024-02-09. These entries reflect progression changes in the trial and its recruitment status.SummaryDifference0.1%

- Check45 days agoChange DetectedMajor update: alerts about government funding status and a new v3.2.0 release. Prior version v3.1.0 was removed.SummaryDifference13%

- Check53 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check67 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, with no changes to pricing or core content.SummaryDifference0.8%

- Check74 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.8%

Stay in the know with updates to Magrolimab Combo in New AML/HR-MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in New AML/HR-MDS Clinical Trial page.